Trials / Completed
CompletedNCT02611076
Smoking-cessation: A Spanish-Language Clinical Trial
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-Language Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop and test a series of culturally relevant and appropriate booklets in Spanish, designed to assist Hispanic smokers in quitting smoking and remaining smoke-free.
Detailed description
Study Aim 1: To transcreate the existing English-language 10 "Stop Smoking for Good" booklets and accompanying 9 supportive "My Story" pamphlets into a series of culturally relevant and acceptable materials for Spanish-speaking smokers who prefer to receive health information in Spanish. The adaptation of the intervention materials will be based upon the findings from a systematic formative evaluation employing a heterogeneous group of Hispanic/Latino smokers representing diverse subcultural groups. Study Aim 2: To test the efficacy of the self-help intervention developed in Study I among Spanish-speaking smokers in a randomized controlled trial. Participants (500) will be randomized to receive the Spanish-language version of the Stop Smoking for Good (SS-SP) intervention or usual care (UC) comprising an existing booklet from NCI. Investigators hypothesize SS-SP will produce higher abstinence rates than UC through 24 months. Secondary Aim: Test moderator variables to improve targeting the intervention. Moderator analyses will be exploratory, without strong a priori hypotheses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Stop Smoking for Good Intervention in Spanish (SS-SP) | Assessments will occur at six-month intervals, through 24 months. |
| BEHAVIORAL | Usual care (UC) | Assessments will occur at six-month intervals, through 24 months. |
Timeline
- Start date
- 2015-10-15
- Primary completion
- 2016-10-11
- Completion
- 2021-10-28
- First posted
- 2015-11-20
- Last updated
- 2022-01-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02611076. Inclusion in this directory is not an endorsement.